Zhejiang Ausun Pharmaceutical Co Ltd (603229) — Financial Flexibility Index
Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Financial Flexibility Index of 0.21x as of September 2025. Free cash flow of CN¥149.17 Million (operating CF CN¥121.49 Million minus capex CN¥27.68 Million) represents 0% of total liabilities (CN¥713.05 Million). Check how strategically is Zhejiang Ausun Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Ausun Pharmaceutical Co Ltd Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Zhejiang Ausun Pharmaceutical Co Ltd across 14 annual periods. See Zhejiang Ausun Pharmaceutical Co Ltd (603229) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Ausun Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Zhejiang Ausun Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥260.95 Million | CN¥156.51 Million | CN¥815.89 Million | ▼ -21.4% |
| 2024 | 0.41x | CN¥289.23 Million | CN¥177.93 Million | CN¥710.50 Million | ▼ -14.4% |
| 2023 | 0.48x | CN¥385.32 Million | CN¥221.85 Million | CN¥809.99 Million | ▲ +3.5% |
| 2022 | 0.46x | CN¥392.48 Million | CN¥120.57 Million | CN¥854.19 Million | ▼ -44.6% |
| 2021 | 0.83x | CN¥484.75 Million | CN¥173.90 Million | CN¥584.64 Million | ▼ -8.7% |
| 2020 | 0.91x | CN¥231.43 Million | CN¥138.47 Million | CN¥254.81 Million | ▲ +59.3% |
| 2019 | 0.57x | CN¥137.36 Million | CN¥87.73 Million | CN¥240.96 Million | ▲ +75.0% |
| 2018 | 0.33x | CN¥66.56 Million | CN¥11.50 Million | CN¥204.38 Million | ▼ -43.1% |
| 2017 | 0.57x | CN¥101.15 Million | CN¥46.78 Million | CN¥176.65 Million | ▼ -14.6% |
| 2016 | 0.67x | CN¥136.00 Million | CN¥93.21 Million | CN¥202.76 Million | ▲ +48.7% |
| 2015 | 0.45x | CN¥96.43 Million | CN¥53.63 Million | CN¥213.81 Million | ▲ +84.2% |
| 2014 | 0.24x | CN¥44.53 Million | CN¥21.45 Million | CN¥181.90 Million | ▼ -31.9% |
| 2013 | 0.36x | CN¥52.44 Million | CN¥15.73 Million | CN¥145.87 Million | ▲ +10.8% |
| 2012 | 0.32x | CN¥36.40 Million | CN¥-1.14 Million | CN¥112.21 Million | — |